Xiaowen Zhang, Ka-Shing Cheung, Lung-Yi Mak, Kathryn C B Tan, Annie W C Kung, Ian Chi-Kei Wong, Ching-Lung Cheung
{"title":"低骨矿密度是肝硬化的风险因素:一项前瞻性队列研究","authors":"Xiaowen Zhang, Ka-Shing Cheung, Lung-Yi Mak, Kathryn C B Tan, Annie W C Kung, Ian Chi-Kei Wong, Ching-Lung Cheung","doi":"10.1210/clinem/dgae223","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Bone metabolism interplays with liver metabolism, also known as the liver-bone axis. Osteoporosis is a common complication of cirrhosis, but whether bone mineral density (BMD) can predict cirrhosis development is unknown.</p><p><strong>Objective: </strong>This study aims to investigate the relationship between BMD and the risk of incident cirrhosis in the Hong Kong Osteoporosis Study (HKOS).</p><p><strong>Methods: </strong>BMD was measured at the lumbar spine, femoral neck, total hip, and trochanter of 7752 participants by dual-energy x-ray absorptiometry (DXA), and the incidence of cirrhosis and mortality were followed by linking to the territory-wide electronic health records database. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CI.</p><p><strong>Results: </strong>With a median follow-up of 18.43 years, 42 incident cirrhosis were identified. Higher BMD T-scores at the femoral neck, total hip, and trochanter were significantly associated with a reduced risk of cirrhosis (femoral neck: HR 0.56; 95% CI, 0.39-0.82; total hip: HR 0.60; 95% CI, 0.44-0.82; trochanter: HR 0.63; 95% CI, 0.46-0.88). Similar associations were observed in participants without risk factors of cirrhosis at the baseline and further adjusting for the baseline level of alkaline phosphatase, albumin, and alanine transaminase. Consistent relationships in multiple sensitivity analyses suggest the robustness of the results.</p><p><strong>Conclusion: </strong>Low BMD could be a novel risk factor and early predictor for cirrhosis, with consistent associations observed in multiple sensitivity analyses.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e276-e282"},"PeriodicalIF":5.0000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis.\",\"authors\":\"Xiaowen Zhang, Ka-Shing Cheung, Lung-Yi Mak, Kathryn C B Tan, Annie W C Kung, Ian Chi-Kei Wong, Ching-Lung Cheung\",\"doi\":\"10.1210/clinem/dgae223\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>Bone metabolism interplays with liver metabolism, also known as the liver-bone axis. Osteoporosis is a common complication of cirrhosis, but whether bone mineral density (BMD) can predict cirrhosis development is unknown.</p><p><strong>Objective: </strong>This study aims to investigate the relationship between BMD and the risk of incident cirrhosis in the Hong Kong Osteoporosis Study (HKOS).</p><p><strong>Methods: </strong>BMD was measured at the lumbar spine, femoral neck, total hip, and trochanter of 7752 participants by dual-energy x-ray absorptiometry (DXA), and the incidence of cirrhosis and mortality were followed by linking to the territory-wide electronic health records database. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CI.</p><p><strong>Results: </strong>With a median follow-up of 18.43 years, 42 incident cirrhosis were identified. Higher BMD T-scores at the femoral neck, total hip, and trochanter were significantly associated with a reduced risk of cirrhosis (femoral neck: HR 0.56; 95% CI, 0.39-0.82; total hip: HR 0.60; 95% CI, 0.44-0.82; trochanter: HR 0.63; 95% CI, 0.46-0.88). Similar associations were observed in participants without risk factors of cirrhosis at the baseline and further adjusting for the baseline level of alkaline phosphatase, albumin, and alanine transaminase. Consistent relationships in multiple sensitivity analyses suggest the robustness of the results.</p><p><strong>Conclusion: </strong>Low BMD could be a novel risk factor and early predictor for cirrhosis, with consistent associations observed in multiple sensitivity analyses.</p>\",\"PeriodicalId\":50238,\"journal\":{\"name\":\"Journal of Clinical Endocrinology & Metabolism\",\"volume\":\" \",\"pages\":\"e276-e282\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2025-01-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Endocrinology & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1210/clinem/dgae223\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae223","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:骨代谢与肝代谢相互影响,又称肝骨轴。骨质疏松症是肝硬化的常见并发症,但骨矿物质密度(BMD)能否预测肝硬化的发展尚不清楚:本研究旨在调查香港骨质疏松症研究(HKOS)中骨密度与肝硬化发病风险之间的关系:方法:采用双能 X 射线吸收仪(DXA)测量了 7,752 名参与者腰椎、股骨颈、全髋和转子的 BMD,并与全港电子健康记录数据库连接,跟踪肝硬化发病率和死亡率。研究采用 Cox 比例危险模型估算危险比(HR)和 95% CI:中位随访时间为 18.43 年,共发现 42 例肝硬化。股骨颈、全髋和转子处较高的 BMD T 值与肝硬化风险的降低显著相关(股骨颈:HR 0.56,95% CI 0.39 至 0.82;全髋:HR 0.60,95% CI 0.60):股骨颈:HR 0.56,95% CI 0.39 至 0.82;全髋:HR 0.60,95% CI 0.44 至 0.82;转子:HR 0.63,95% CI 0.46 至 0.88)。在基线没有肝硬化风险因素的参与者中,以及进一步调整碱性磷酸酶、白蛋白和丙氨酸转氨酶的基线水平后,也观察到了类似的关联。多个敏感性分析中的关系一致,表明结果的稳健性:低 BMD 可能是肝硬化的一个新的风险因素和早期预测因子,在多个敏感性分析中观察到了一致的关系。
Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis.
Context: Bone metabolism interplays with liver metabolism, also known as the liver-bone axis. Osteoporosis is a common complication of cirrhosis, but whether bone mineral density (BMD) can predict cirrhosis development is unknown.
Objective: This study aims to investigate the relationship between BMD and the risk of incident cirrhosis in the Hong Kong Osteoporosis Study (HKOS).
Methods: BMD was measured at the lumbar spine, femoral neck, total hip, and trochanter of 7752 participants by dual-energy x-ray absorptiometry (DXA), and the incidence of cirrhosis and mortality were followed by linking to the territory-wide electronic health records database. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CI.
Results: With a median follow-up of 18.43 years, 42 incident cirrhosis were identified. Higher BMD T-scores at the femoral neck, total hip, and trochanter were significantly associated with a reduced risk of cirrhosis (femoral neck: HR 0.56; 95% CI, 0.39-0.82; total hip: HR 0.60; 95% CI, 0.44-0.82; trochanter: HR 0.63; 95% CI, 0.46-0.88). Similar associations were observed in participants without risk factors of cirrhosis at the baseline and further adjusting for the baseline level of alkaline phosphatase, albumin, and alanine transaminase. Consistent relationships in multiple sensitivity analyses suggest the robustness of the results.
Conclusion: Low BMD could be a novel risk factor and early predictor for cirrhosis, with consistent associations observed in multiple sensitivity analyses.
期刊介绍:
The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.